Follow @UKGovscan on X for updates and inquiries

UKGovscanBETA

BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.

Loading contract…

PHE - Corporate - Newborn Screening for Cystic Fibrosis — UK Health Security Agency | UKGovscan

ENDEDProcurement notice · UK Health Security AgencyRef ocds-b5fd17-af33a23f-e5d3-4d89-b9f4-d14e4aabc59f

PHE - Corporate - Newborn Screening for Cystic Fibrosis

Save Track Track buyer

Published

4 Nov 2021

Awarded

1 Nov 2021

Started

1 Nov 2021

Ended

30 Nov 2022

Total Awarded

£99,696

Contract Term

13 months

1 Nov 2021 – 30 Nov 2022

Supplier

City, University of London

Company RC000121

Procurement

Other -

Source

Contracts Finder

View original notice

Description

Determining the impact of employing next generation genomic sequencing (NGS) as part of the method of newborn screening for Cystic Fibrosis (CF): a stakeholder engagement project

Buyer

Organisation: UK Health Security Agency
Buyer ID: GB-CFS-188149
Local Authority Code: –
Address: Public Health England, Wellington House, 133-155 Waterloo Road, London, SE1 8UG, GB

Supplier

Supplier	Identifier	Award Value	Cross-References
City, University of London	RC000121	£99,696	-

Key Dates

Published: 4 November 2021
Tender Open: -
Tender Deadline: 27 August 2021
Award Date: 1 November 2021
Contract Start: 1 November 2021
Contract End: 30 November 2022

Procurement Details

Method: –
Method Details: Other -
Main category: Services
Category: –
Buyer Reference: CF-0451200D0O000000rwimUAA1
CPV Codes: 75122000 – Administrative healthcare services

Tender Documents

Awarded contract notice on Contracts Finder → — Award notice

Loading contract…